School of Medicine
Showing 51-100 of 644 Results
-
Carolyn K. Pan, MD
Clinical Associate Professor, Ophthalmology
BioDr. Pan is a board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon. She focuses on retinal vascular diseases, macular degeneration, and surgical repair of retinal detachments, macular pathology, and complications from cataract surgery. She has co-authored peer-reviewed articles on topics ranging from optical coherence tomography imaging to embryonic stem cells for macular degeneration.
In addition to her clinical practice, she is dedicated to the education and training of medical students, residents, and fellows. As recognition of her efforts, she received the Faculty Teaching Award in 2016 from the Byers Eye Institute at Stanford University, was the Associate Residency Program Director from 2020 to 2023, and currently serves as the Residency Program Director. Her educational efforts also extend beyond the department - since 2016, she has served on the annual meeting planning committee for the American Academy of Ophthalmology and is currently Associate Secretary of the Annual Meeting and Chair of the Special Projects Committee.
Dr. Pan's clinical practice is mainly based at Santa Clara Valley Medical Center, Stanford's affiliate county hospital, where she is chief of the retina service. -
Jennifer Yi-Jiun Pan
Clinical Assistant Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
Staff, Medicine - Med/Gastroenterology and HepatologyBioMy research interests thus far have focused on immunology, GI cancers, and improving quality of care for patients. I am passionate about understanding the different genetic and lifestyle factors that are involved in GI cancers and other colonic pathology, as well as improving systems of care to better manage the health and improve the outcomes of patients with these diseases. Towards that end, I have been involved in research in Lynch syndrome in order to bridge the gap between our current understanding of cancer risk in this high-risk population and the creation and implementation of guidelines worldwide. I also had the opportunity to work with collaborators in the International Mismatch Repair Consortium at the Department of Colorectal Medicine and Genetics with the Royal Melbourne Hospital in Australia where I saw firsthand the global efforts in the fight against colorectal cancer. In my current role as a staff gastroenterologist at the VA Palo Alto, I oversee the colorectal cancer prevention program. My goal is to continue to be part of and contribute to collaborative clinical and research efforts in order to provide the best care for our patients.
Professional Education:
- Fellowship: Stanford University--Gastroenterology (2016)
- MS: Stanford University--Epidemiology and Clinical Research (2016)
- Residency: Yale-New Haven Hospital--Internal Medicine (2013)
- MD: University of Texas Southwestern Medical Center (2010)
- AB: Harvard College--Biochemical Sciences (2006)
Honors and Awards:
- American College of Gastroenterology North American International GI Training Grant (2016)
Professional Memberships:
- American Gastroenterological Association
-- Delegate, AGA Trainee and Early Career GI Committee (2016-2018)
-- Regional Planner, AGA Regional Practice Skills Workshop – California (2016-2017)
- Northern California Society for Clinical Gastroenterology2014 – Present
-- Education and Trainee Committee (2021-Present)
-- Communications Committee (2021-Present)
Selected NCBI Bibliography: https://www.ncbi.nlm.nih.gov/myncbi/jennifer.pan.1/bibliography/public/ -
Minggui Pan, MD, PhD
Clinical Professor, Medicine - Oncology
BioDr. Pan is a board-certified, fellowship-trained medical oncologist with the Stanford Medicine Cancer Center and a clinical professor in the Department of Medicine, Division of Oncology.
He diagnoses and treats various oncological conditions and specializes in the treatment of bone and soft tissue sarcoma. He creates personalized and comprehensive care plans for each patient he serves.
Dr. Pan’s research focuses include understanding how genomic alterations impact the biological behavior and prognosis of sarcomas. In his work, he identifies new targets for developing innovative therapeutics for sarcoma treatment.
Dr. Pan has more than sixty publications and presented many abstracts in several cancer and immunology conferences. His papers have been published in the Journal of Clinical Oncology, JCO Precision Oncology, Clinical Cancer Research, Nature Review Clinical Oncology, JCO Oncology Practice, Journal of Hematology and Oncology, and other peer-reviewed journals. He has also presented to his peers at international, national, and regional meetings, including the annual meetings of American Society of Clinical Oncology, Chinese Society Of Clinical Oncology, Connective Tissue Oncology Society and others.
Dr. Pan is a member of American Society of Clinical Oncology, American Association of Immunologists, American Association for Advancement of Science, Society for Immunotherapy of Cancer, and Connective Tissue Oncology Society. Dr. Pan is also an adjunct investigator with Kaiser Permanente Division of Research. -
John Christopher (J.C.) Panagides
Affiliate, Department Funds
Resident in Rad/Interventional RadiologyBioCurrent Integrated Interventional and Diagnostic Radiology (IR/DR) Resident at Stanford Medicine and recent graduate of Harvard Medical School (Class of 2023) with deep interests in emerging applications of interventional and diagnostic radiology, minimally invasive procedures, and biomedical engineering. Extensive experience in biomedical project design and clinical research in predictive analytics, radiology practice management, and population health outcomes.
-
Pritam Kumar Panda
Postdoctoral Scholar, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsDr. Panda’s current research at Stanford University School of Medicine centers on the innovative design of anesthetics optimized for battlefield application. His work integrates advanced methodologies such as AI-driven protein design, molecular dynamics simulations, and computational drug design to identify and model potential anesthetic compounds with precision and efficacy.
-
Vijay Pande
Adjunct Professor, Structural Biology
BioVijay Pande, Henry Dreyfus Professor of Chemistry and, by courtesy, of Structural Biology and Computer Science, also currently directs of the Stanford Program in Biophysics and the Folding@home Distribtued Computing project. His research centers on novel cloud computing simulation techniques to address problems in chemical biology. In particular, he has pioneered distributed computing methodology to break fundamental barriers in the simulation of protein and nucleic acid kinetics and thermodynamics. As director of the Folding@home project (http://folding.stanford.edu), Prof. Pande has, for the first time, directly simulated protein folding dynamics, making quantitative comparisons with experimental results, often considered a “holy grail” of computational biology. His current research also includes novel computational methods for drug design, especially in the area of protein misfolding and associated diseases such as Alzheimer’s and Huntington’s Disease.
Professor Pande studied physics at Princeton University (B.A. 1992), where he was first introduced to biophysical questions, especially in undergraduate research with Nobel Laureate P. Anderson. His doctoral research in physics under Profs. T. Tanaka and A. Grosberg at MIT (Ph.D. 1995) centered on statistical mechanical models of protein folding, suggesting new ways to design protein sequences for stability and folding properties. As a Miller Fellow under Prof. D. Rokhsar at UC Berkeley, Prof. Pande extended this methodology to examine atomistic protein models, laying the foundations for his work at Stanford University. Among numerous awards, Prof. Pande has received the Biophysical Society’s Bárány Award for Young Investigators and Protein Society’s Irving Sigal Young Investigator Award, and was named to MIT’s TR100 and elected a Fellow of the American Physical Society.
The Pande research group develops and applies new theoretical methods to understand the physical properties of biological molecules such as proteins, nucleic acids and lipid membranes, using this understanding to design synthetic systems including small-molecule therapeutics. In particular, the group examines the self-assembly properties of biomolecules. For example, how do protein and RNA molecules fold? How do proteins misfold and aggregate? How can we use this understanding to tackle misfolding related degeneration and develop small molecules to inhibit disease processes?
As these phenomena are complex, spanning molecular to mesoscopic lengths and nanosecond to millisecond timescales, the lab employs a variety of methods, including statistical mechanical analytic models, Markov State Models, and statistical and informatic methods. Other tools include Monte Carlo, Langevin dynamics, and molecular dynamics computer simulations on workstations and massively parallel supercomputers, superclusters, and worldwide distributed computing. The group has also done extensive work in the application of machine learning, pioneering traditional and deep learning approaches to cheminformatics, biophysics and drug design.
For example, simulations in all-atom detail on experimentally relevant timescales (milliseconds to seconds) have produced specific predictions of the structural and physical chemical nature of protein aggregation involved in Alzheimer’s and Huntington’s diseases. These results have fed into computational small molecule drug design methods, yielding interesting new chemical entities.
Since such problems are extremely computationally demanding, the group developed a distributed computing project for protein folding dynamics. Since its launch in October 2000, Folding@Home has attracted more than 4,000,000 PCs, and today is recognized as the most powerful supercluster in the world. Such enormous computational resources have allowed simulations of unprecedented folding timescales and statistical precision and accuracy. For more details, please visit http://pande.stanford.edu. -
Mahesh Pandit
Postdoctoral Scholar, Immunology and Rheumatology
BioI have completed my PhD in Immunology from Yeungnam University, South Korea. I studied adaptive immune cells especially focusing T cells and its relation to autoimmunity and tumor. I worked on different conditional knockout mice to investigate the cellular mechanisms. Similarly, I worked on disease induced mice to study its preventive and therapeutic approaches. Currently, I am working on Translational immunology as a Postdoctoral Researcher at Stanford University department of Immunology and Rheumatology. I focus on Epstein-Barr Virus, B cells and its relation with various autoimmune diseases.
-
Anil K. Panigrahi
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Clinical Associate Professor (By courtesy), PathologyBioAnil K. Panigrahi, M.D., Ph.D. is a Clinical Associate Professor in the Departments of Anesthesiology and Pathology (by courtesy) at Stanford University. Board-certified in Anesthesiology and Transfusion Medicine, Dr. Panigrahi works clinically in both specialties.
Additionally, Dr. Panigrahi leads Patient Blood Management initiatives throughout Stanford Medicine and serves as Stanford Anesthesiology Director of Patient Blood Management, Chair of the Stanford Health Care Transfusion Committee, Medical Director of Stanford Anesthesiology’s Perioperative Anemia Management Clinic, and an Assistant Medical Director of the Stanford Health Care Transfusion Service.
Dr. Panigrahi is a contributor to leading academic textbooks of Anesthesiology and Transfusion Medicine, including Miller’s Anesthesia and the Association for the Advancement of Blood & Biotherapies (AABB) Technical Manual. He regularly lectures at national conferences and has presented at annual meetings for the American Society of Anesthesiologists (ASA), AABB, and the Society for the Advancement of Patient Blood Management (SABM). He is an active member of the ASA, serving on the ASA’s Committee on Patient Blood Management since 2018, and is also a member of the AABB, SABM, and the California Society of Anesthesiologists (CSA), where he has served as a District Delegate.
A Phi Beta Kappa graduate of Duke University, Dr. Panigrahi received his M.D. and Ph.D. degrees from the University of Pennsylvania School of Medicine, where he was awarded the John G. Clark Prize for meritorious research. He completed residency training in Anesthesiology at Stanford University and fellowship in Blood Banking/Transfusion Medicine in the Department of Pathology also at Stanford. -
Heather Ryan Pankow
Life Science Rsch Prof 2, Psych/General Psychiatry and Psychology (Adult)
Current Role at StanfordLife Science Research Professional 2 in The Depression Research Clinic
-
Jaspreet Pannu
Clinical Scholar, Medicine
Postdoctoral Scholar, General Internal MedicineBioJassi Pannu, MD is a Physician and Fellow within Stanford University's School of Medicine.
-
Sofia Pantis
Research Assistant, Neurology
Current Role at StanfordResearch Assistant - Laboratory of Behavioral and Cognitive Neuroscience (Parvizi Lab) - Stanford School of Medicine, Department of Neurology and Neurological Sciences
-
Lori D Panu
Sr. Program Manager, Clinical Research Operations, Med/Stanford Center for Clinical Research
Current Role at StanfordSr. Program Manager, Clinical Research Operations
-
Alan C. Pao
Associate Professor of Medicine (Nephrology) and, by courtesy, of Urology
Current Research and Scholarly InterestsWe are broadly interested in how the kidneys control salt, water, and electrolyte homeostasis in the body. Our disease focus is on kidney stone disease. We use cultured kidney cells, transgenic mice, human plasma/urine samples, and electronic health record data to study the pathogenesis of kidney stone disease. Our therapeutic focus is on the development of small molecule compounds that can be used for kidney stone prevention.
